Clinical trial
Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)
NCT00781573 is registered in ClinicalTrials.gov with North Texas Veterans Healthcare System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)
- Lead sponsor
- North Texas Veterans Healthcare System
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 11, 2008
- Completion date
- March 3, 2014
- Enrollment
- 167 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.